Alta Futuris has exceptional  Machine learning in clinical trials that can help predict the result of clinical trials that ultimately lead to reduced costs, faster drug approval, and more funding to develop advanced treatments to deliver the best of the facility to patients. To increase clinical trial efficiency, researchers use the largest set of data to develop machine learning algorithms. The development has successfully analyzed over 140 features, including sponsor track record, trial status, accrual rates, and duration to predict clinical trial results. These results or predictions are used by investors and drug developers to effectively find out the risks associated with different investigational drugs at each clinical-stage, ultimately offering them with required transparency.
http://www.altafuturis.com/